We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$81.2M
AUM Growth
-$72.9B
Cap. Flow
+$869M
Cap. Flow %
1,070.28%
Top 10 Hldgs %
17.7%
Holding
5,106
New
989
Increased
1,503
Reduced
1,793
Closed
724

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$278M
2
INTC icon
Intel
INTC
+$223M
3
PPLI
People Inc
PPLI
+$210M
4
MA icon
Mastercard
MA
+$210M
5
HON icon
Honeywell
HON
+$188M

Sector Composition

Rank Sector Weight
1 Healthcare 8.4%
2 Consumer Discretionary 6.7%
3 Technology 6.04%
4 Industrials 5.81%
5 Financials 5.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGC
4426
Canopy Growth
CGC
$386M
-3,720
Closed -$601K
CIB icon
4427
Grupo Cibest SA
CIB
$22B
-43,986
Closed -$1.16M
CLDX icon
4428
CALL
Celldex Therapeutics
CLDX
$2.95B
-31,200
Closed -$406K
CLDX icon
4429
Celldex Therapeutics
CLDX
$2.95B
-430,564
Closed -$5.6M
CLFD icon
4430
Clearfield
CLFD
$418M
-10,565
Closed -$147K
CLOU icon
4431
Global X Cloud Computing ETF
CLOU
$240M
-199,948
Closed -$4.28M
CLRB icon
4432
Cellectar Biosciences
CLRB
$21.1M
-47
Closed -$18K
CLSD
4433
DELISTED
Clearside Biomedical
CLSD
-9,642
Closed -$272K
CLX icon
4434
CALL
Clorox
CLX
$11.6B
-5,000
Closed -$1.1M
CMS icon
4435
PUT
CMS Energy
CMS
$22.6B
-5,400
Closed -$315K
CNC icon
4436
PUT
Centene
CNC
$30.8B
-18,900
Closed -$1.2M
CODA icon
4437
Coda Octopus Group
CODA
$116M
-24,441
Closed -$126K
COHU icon
4438
Cohu
COHU
$2.3B
-188,150
Closed -$3.26M
COO icon
4439
CALL
Cooper Companies
COO
$14.1B
-20,000
Closed -$1.42M
COO icon
4440
PUT
Cooper Companies
COO
$14.1B
-8,000
Closed -$567K
COOP
4441
DELISTED
Mr. Cooper
COOP
-54,693
Closed -$680K
CP icon
4442
Canadian Pacific Kansas City
CP
$78.2B
-1,798,730
Closed -$91.9M
CRBP icon
4443
Corbus Pharmaceuticals
CRBP
$165M
-16,006
Closed -$4.03M
CRESY
4444
Cresud
CRESY
$796M
-21,803
Closed -$62K
CRI icon
4445
Carter's
CRI
$1.4B
-59,128
Closed -$4.77M
CRMT icon
4446
America's Car Mart
CRMT
$26.6M
-8,948
Closed -$786K
CRNX icon
4447
Crinetics Pharmaceuticals
CRNX
$8.86B
-113,034
Closed -$1.98M
CRON
4448
Cronos Group
CRON
$1.06B
-19,481
Closed -$117K
CRSP icon
4449
CALL
CRISPR Therapeutics
CRSP
$4.73B
-25,000
Closed -$1.84M
CRSP icon
4450
CRISPR Therapeutics
CRSP
$4.73B
-20,592
Closed -$1.51M

Similar funds

Millennium Management's Q3 2020 Portfolio in Review

As of Q3 2020, Millennium Management held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Millennium Management deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.

By sector, the portfolio is most concentrated in Healthcare at 8.4% of assets, down from 8.6% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.

  • Millennium Management's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
  • Millennium Management added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
  • Millennium Management's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
  • Millennium Management fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
  • Millennium Management's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
  • Millennium Management opened 989 new positions and closed 724 in Q3 2020.
  • Millennium Management's portfolio value fell 100% quarter-over-quarter to $81.2M.

Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.